Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Stifel Downgrades CTI BioPharma to Hold, Raises Price Target to $9.1

Author: Benzinga Newsdesk | May 15, 2023 07:45am

Stifel analyst Benjamin Burnett downgrades CTI BioPharma (NASDAQ:CTIC) from Buy to Hold and raises the price target from $8.1 to $9.1.

Posted In: CTIC